Prognostic Factors and Long-Term Efficacy of Tonsillectomy in 17 Patients with Pustulotic Arthro-Osteitis.
Prognosis
osteitis
tonsillectomy
visual analog scale
Journal
The Eurasian journal of medicine
ISSN: 1308-8734
Titre abrégé: Eurasian J Med
Pays: Turkey
ID NLM: 101557701
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
ppublish
Résumé
In this case study, we aimed to evaluate the disease condition of patients with pustulotic arthro-osteitis (PAO) at 36-month post-tonsillectomy. A retrospective analysis of the cases of 17 patients with PAO who were resistant to initial systemic treatments and underwent tonsillectomy at our hospital in 2006-2016 was conducted. The patients' disease condition at 1-, 24-, and 36-month post-tonsillectomy was assessed by the visual analog scale (VAS) score for osteoarthropathic pain, the disease duration, the area of palmoplantar lesions, and the Palmoplantar Pustular Psoriasis Area Severity Index (ppPASI). In the minimum follow-up of 36-month post-tonsillectomy in 17 patients, the median ppPASI and VAS scores decreased from 12 to 1 and from 80 to 20, respectively. Thirteen patients with ≥70% improvement in their VAS scores maintained the same good condition after ≥36 months, whereas four patients with <70% improvement in their VAS scores did not show remarkable improvement after that time point. Furthermore, we found that the improvement in VAS score was not associated with the disease duration or the patients' pre-tonsillectomy ppPASI values. Tonsillectomy might be an alternative treatment option for patients with PAO. Long-term efficacy against pain can be predicted by evaluating a patient's improvement at 1-month post-tonsillectomy.
Identifiants
pubmed: 32158326
doi: 10.5152/eurasianjmed.2019.19099
pii: eajm-52-1-103
pmc: PMC7051221
doi:
Types de publication
Journal Article
Langues
eng
Pagination
103-105Informations de copyright
©Copyright 2020 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors have no conflicts of interest to declare.
Références
Clin Exp Immunol. 2013 Oct;174(1):139-51
pubmed: 23750651
Clin Immunol. 2005 Jul;116(1):42-53
pubmed: 15925831
Adv Otorhinolaryngol. 2011;72:86-8
pubmed: 21865698
Br J Dermatol. 2001 Oct;145(4):546-53
pubmed: 11703279
Br J Dermatol. 2001 Dec;145(6):886-90
pubmed: 11899140
Ann Rheum Dis. 1981 Dec;40(6):547-53
pubmed: 7332374
J Dermatol. 2013 Nov;40(11):857-63
pubmed: 24127744
J Dermatol. 2018 Jul;45(7):812-823
pubmed: 29732605
Adv Otorhinolaryngol. 2011;72:89-92
pubmed: 21865699
J Dermatol. 2017 Jan;44(1):97-98
pubmed: 27162198